Logo Asphalion

EU-FUNDED PROJECT | UroPrint kick-off meeting

Last week, Luis Borges Rocha represented Asphalion at the UroPrint kick-off meeting, another H2020 EU-funded project in which Asphalion participates as Regulatory Affairs partner.

Last week, Luis Borges Rocha represented Asphalion at the UroPrint kick-off meeting, another H2020 EU-funded project in which Asphalion participates as Regulatory Affairs partner.
September 28, 2021

Last week, Luis Borges Rocha represented Asphalion at the UroPrint kick-off meeting, another H2020 EU-funded project in which Asphalion participates as Regulatory Affairs partner.

The complete name of the project is: “Urinary bladder bioprinting for fully autologous transplantation” and aims at developing revolutionary tissue engineering and bioprinting technics to generate bladder tissue for autologous transplantation in patients.

The meeting took place online and was a great opportunity for all partners involved to present their action plans for each work package, as well as to coordinate the working strategy to be followed during project development.

More details about the UroPrint project can be accessed through the European Commission at: https://cordis.europa.eu/project/id/964883

✹For further information, you can also contact us at: 📧  horizon@asphalion.com

Search News & Events

  • Filter by category

Share

Related news and events

In2Sight | 4th annual meeting 3RS congress

At ASPHALION, we are part of the IN2SIGHT consortium, an EU-funded project, and we are delighted to be currently participating in the 4th annual meeting

Course | Regulatory aspects of vaccine development

TRANSVAC2 supported innovation for both prophylactic and therapeutic vaccine development by providing high-quality technical services across four different service platforms: Technology (for process development and GMP production), Immunocorrelates & Systems Biology, Animal models, and support for Clinical Trials. TRANSVAC also offered training courses to provide fundamental and advanced knowledge on a wide-range of vaccine development-related topics.

ASPHALION HIGHLIGHTS Q2 2023

A lot of things have happened during these past three months. We received an award from AEFI as most engaged Company with its employees’ traning;

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting